Journal
NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS
Volume 135, Issue -, Pages -Publisher
PERGAMON-ELSEVIER SCIENCE LTD
DOI: 10.1016/j.neubiorev.2022.104551
Keywords
Sugar; Glucose; Cognition; Dementia; Beta-amyloid; Neurodegeneration
Categories
Ask authors/readers for more resources
This systematic review explores the association between blood glucose levels and cognition, dementia risk, and related biomarkers in adults without diabetes or metabolic syndrome. The results suggest that higher blood glucose may contribute to dementia-related neuropathology, but the impact on cognitive decline or dementia risk later in life remains unclear.
Background: Excessive blood glucose promotes neuropathological cognitive decline in individuals with type 2 diabetes mellitus and the metabolic syndrome, but no systematic synthesis of the evidence for the same asso-ciation exists in individuals without these conditions. Objectives: To systematically review studies exploring the role of glucose on cognition, dementia risk, and related biomarkers in adults without diabetes or metabolic syndrome. Data sources: We searched databases from inception until July 2021 and manually searched the reference lists of included studies. Risk of bias was assessed using the Joanna Briggs Institute tool. Results: We found 46 observational studies including approximately 98,216 participants. Substantial heteroge-neity in study results precluded drawing definitive conclusion whether blood glucose levels are associated with cognition or dementia risk. Higher blood glucose, however, was associated with greater amyloid burden, brain atrophy, and reduced cortical thickness. Conclusions and implications: High glucose concentrations in blood may exacerbate dementia-related neuropa-thology but whether this translates into pathological cognitive decline or elevate dementia risk later in life re-mains unclear.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available